• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (2): 300-304.DOI: 10.3969/j.issn.1671-2587.2026.02.024

• 综述 • 上一篇    

红细胞深低温保存技术:多尺度保护剂创新与临床转化的跨学科研究进展

陈智源, 林华雨, 孙莉萍, 于洋   

  1. 解放军总医院第一医学中心输血医学科,北京 100853
  • 收稿日期:2025-09-26 接受日期:2025-12-02 出版日期:2026-04-20 发布日期:2026-04-22
  • 通讯作者: 于洋,主要从事输血医学与单采治疗,(E-mail)yuyang301@163.com。
  • 作者简介:陈智源,主要从事红细胞储存,(E-mail)1943512920@qq.com。

Deep Cryopreservation of Red Blood Cells: Advances in Interdisciplinary Research on Multiscale Cryoprotective Agents and Clinical Translation

CHEN Zhiyuan, LIN Huayu, SUN Liping, YU Yang   

  1. Department of Transfusion Medicine, The First Medical Center of Chinese PLA General Hospital, Beijing 100853
  • Received:2025-09-26 Accepted:2025-12-02 Online:2026-04-20 Published:2026-04-22

摘要: 红细胞深低温贮存是确保临床血液安全和公共卫生事件应急响应的关键技术。甘油型保护剂可实现长时间贮存,但因高渗透压产生的复杂冲洗流程、单位体积保存的红细胞数量低,以及较严重的细胞功能损伤,限制了其在国内和新兴(发展中国家)低收入地区的推广应用。近年来,材料学、纳米技术与合成生物学的交叉融合为红细胞深低温保存技术进步提供了全新思路:免洗非甘油保护剂通过分子界面工程(如海藻糖壳聚糖纳米纤维支架、聚乙烯吡咯烷酮梯度系统)发挥作用;物理化学保护纳米复合材料(如介孔二氧化硅、温度响应水凝胶)也展现出良好前景。本文整理多项临床研究结果,从技术-经济-政策三个角度对深低温技术发展进行多维度综合考量。免洗新式红细胞保护剂通过创新配方设计,在保证冷冻保护效果和红细胞解冻后质量的同时,完全省去或极大简化了解冻后繁琐的洗涤步骤,实现冰冻红细胞快速解冻、即刻可用,使冰冻红细胞从“冰箱储备”转变为“急救箱储备”。然而,纳米材料的生物相容性、安全性及高效低成本的高通量保护剂筛选体系缺失,以及冷冻设备在低温条件下的能耗不足等问题,仍是红细胞保存技术突破及临床推广使用的最大障碍。今后需加强多学科交叉合作研发,推动红细胞体外保存技术向多功能可控和低成本应用方向发展。

关键词: 冰冻红细胞, 非甘油保护剂, 海藻糖, 界面工程, 纳米复合材料

Abstract: Cryopreservation of red blood cells is a key technology to ensure the safety of clinical blood and emergency response to public health incidents. Glycerol-based protectants can achieve long-term storage, but their promotion and application in China and emerging (developing) low-income regions are limited due to the complex washing process caused by high osmotic pressure, the low number of red blood cells preserved per unit volume, and relatively serious damage to cell functions. In recent years, the cross-integration of materials science, nanotechnology, and synthetic biology has provided new ideas for the advancement of red blood cell cryopreservation technology: wash-free non-glycerol protectants function through molecular interface engineering (such as trehalose-chitosan nanofiber scaffolds, polyvinylpyrrolidone gradient systems); physicochemical protective nanocomposites (such as mesoporous silica, temperature-responsive hydrogels) have also shown good prospects. This article collates the results of multiple clinical studies and conducts a multi-dimensional comprehensive consideration of the development of cryogenic technology from the three perspectives of technology, economy, and policy. Through innovative formula design, the new wash-free red blood cell protectants not only ensure the cryoprotective effect and the quality of red blood cells after thawing but also completely eliminate or greatly simplify the tedious washing steps after thawing, enabling rapid thawing and immediate use of frozen red blood cells, thus transforming frozen red blood cells from "refrigerator reserves" to "first-aid kit reserves". However, issues such as the biocompatibility and safety of nanomaterials, the lack of an efficient, low-cost, high-throughput protectant screening system, and insufficient energy consumption of freezing equipment under low-temperature conditions remain the biggest obstacles to the breakthrough and clinical promotion of red blood cell preservation technology. In the future, it is necessary to strengthen interdisciplinary collaborative research and development to promote the development of in vitro red blood cell preservation technology towards multi-functional control and low-cost application.

Key words: Frozen red blood cells, Non-glycerol protectants, Trehalose, Interface engineering, Nanocomposites

中图分类号: